Lupin launches generic AndroGel

Press enter to search
Close search
Open Menu

Lupin launches generic AndroGel

By Sandra Levy - 04/25/2019
Lupin is launching testosterone gel, 1.62% (20.25 mg/1.25 g pump actuation).

Lupin's product is the generic of AbbVie's AndroGel, 1.62%. It is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired).

Testosterone gel, 1.62% (20.25 mg/1.25 g pump actuation) had a market value of approximately $893 million, according to December 2018 IQVIA data.

RELATED TOPICS